Patient Guide: A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 165 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05457283
Status: 🟢 Enrolling Now
Condition: Chronic Kidney Disease, Proteinuria, Children
Phase: PHASE3

Where You Can Participate

This study is available at 165 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Los Angeles, California
  • • Palo Alto, California
  • • And 162 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria - Join Clinical Trial NCTNCT05457283

How to Join This Clinical Trial - NCTNCT05457283

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Kidney Disease, Proteinuria, Children. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Kidney Disease, Proteinuria, Children. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Kidney Disease, Proteinuria, Children
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05457283 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 165 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85016 - United States

Status: WITHDRAWN

Clinical Research Site

Los Angeles, California 90048 - United States

Status: WITHDRAWN

Clinical Research Site

Palo Alto, California 94304 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

San Diego, California 92123 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Washington, District of Columbia 20010 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hollywood, Florida 33021 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: WITHDRAWN

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Boston, Massachusetts 02115 - United States

Status: WITHDRAWN

And 155 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Kidney Disease, Proteinuria, Children:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships